Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
03/03 U.S. stocks recede from record highs, dollar slips
03/03DJBOND REPORT : Treasury Yields Rise As Investors Buy Corporate Debt
03/03DJActavis Launches $21 Billion Bond Sale
03/03DJU.S. Government Bonds Fall, as Corporate Sales Compete
03/03DJActavis Lowers Yields On Megabond Sale
03/03 ASTRAZENECA : Acquisition of Rights to Actavis' Portfolio
03/03DJASTRAZENECA : Completes Acquisition of Rights to Actavis' Portfolio
03/03DJAstraZeneca PLC Acquisition of Rights to Actavis' Portfolio
03/03 ACTAVIS : Adamas Reports Fiscal 2014 Financial Results
03/02 ACTAVIS : and Medicines360 get FDA approval for pregnancy prevention drug Lilett..
03/02 ACTAVIS : Entry into a Material Definitive Agreement, Material Modification to R..
03/02DJActavis to Wrap Up Mega-Bond Sale on Tuesday
03/02 ACTAVIS : Announces Closing of Public Offerings of Ordinary Shares and Mandatory..
03/02DJU.S. Government Bonds Sell Off Again After Brutal February
03/02DJU.S. Treasurys Off to Rough Start in March
03/02DJActavis to Tap Bond Market This Week With Mega Deal
03/02 ACTAVIS : Receives Approval from the European Commission for XYDALBA(TM) (dalbav..
03/02 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
03/02 ACTAVIS : Announces Proposed Public Offering of Senior Notes in Connection with ..
03/02DJMARKET SNAPSHOT : U.S. Stocks: Futures Edge Higher Ahead Of Data Deluge
03/02DJMARKET SNAPSHOT : U.S. Stocks: Futures Climb Ahead Of Data Deluge
03/02 ACTAVIS : Readies Big Bond Deal
03/01DJActavis Readies Big Bond Deal
02/27 ACTAVIS : Novan Expands Leadership Team with Vice President of Regulatory Affair..
02/27 AstraZeneca to carve out antibiotic R&D into separate firm
02/26 ACTAVIS : Launches Generic Pulmicort RESPULES®
02/26 ACTAVIS : Announces Intention to Adopt "Allergan" Corporate Name
02/25 ALLERGAN : Actavis Announces Proposed Public Offerings of Ordinary Shares and Ma..
02/25 ACTAVIS : FDA approves new antibiotic combo from Actavis
02/25 ACTAVIS : Receives U.S. FDA Approval for AVYCAZ(TM) (CEFTAZIDIME-AVIBACTAM)
02/25 ACTAVIS : Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 201..
02/25 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
02/25 ACTAVIS : Announces Pricing of Public Offerings of Ordinary Shares and Mandatory..
02/24 ACTAVIS : Confirms Generic Uceris® Patent Challenge
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- 2nd Update
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- Update
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion
02/21DJValeant Nears Deal to Buy Salix
02/21 ACTAVIS : Launches Generic Pulmicort Respules
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 ACTAVIS : Receives Final Approval for Generic Version of Subutex®
02/20 ACTAVIS : launches the "Unconditional Love" Campaign to Recognize Alzheimer's Di..
02/19 ACTAVIS : to Divest Pharmatech to TPG
02/19 ACTAVIS : Outlines Standalone Pharmaceutical Pipeline at Investor Meeting
02/19 ALLERGAN : Actavis Announces Intention to Adopt "Allergan" Corporate Name
02/19DJACTAVIS : to Sell $8.4 Billion in Shares to Fund Allergan Acquisition
02/19 ACTAVIS : Announces Proposed Public Offerings of Ordinary Shares and Mandatory C..
02/19 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
02/19 ACTAVIS : to take Allergan name
02/18 ACTAVIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
02/18DJMARKET SNAPSHOT : U.S. Stocks: Futures Edge Lower After Housing, Inflation Data
02/18 ALLERGAN : Actavis plans name change to Allergan
02/18DJActavis Earnings Soar as Closing of Allergan Deal Looms -- Update
02/18DJMARKET SNAPSHOT : U.S. Stocks: Futures Search For Direction Ahead Of FOMC Minute..
02/18DJMARKET SNAPSHOT : U.S. Stocks: Futures Searching For Direction Ahead Of FOMC Min..
02/18DJActavis Earnings Soar as Closing of Allergan Deal Looms
02/18 ACTAVIS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
02/18 ACTAVIS : Announces Intention to Adopt "Allergan" Corporate Name
02/18 ACTAVIS : reports 4Q loss
02/18 ACTAVIS : Outlines Standalone Pharmaceutical Pipeline at Investor Meeting
02/18 ACTAVIS : Results of Operations and Financial Condition, Financial Statements an..
02/18 ACTAVIS : Releases Generic Pulmicort Respules
02/17 ACTAVIS : Confirms Temporary Injunction From Appeals Court Related to Generic Pu..
02/16 ACTAVIS : introduces generic version of AstraZeneca's Pulmicort Respules
02/15 AstraZeneca's patent on asthma drug invalidated by U.S. court
02/15 ACTAVIS : to Sell Doryx to Mayne Pharma
02/13 ACTAVIS : Launches Generic Pulmicort RESPULES®
02/13 ACTAVIS : TPG to Acquire Actavis' (ACT) Aptalis Pharmatech Unit
02/13 ACTAVIS : to Divest Pharmatech to TPG
02/13 ACTAVIS : AMRI Announces Fourth Quarter and Full Year 2014 Results
02/12 ACTAVIS : to Sell Doryx to Mayne Pharma
02/11 ACTAVIS : Announces FDA Acceptance of sNDA to Expand TEFLARO® ceftaroline fosami..
02/11 ACTAVIS : Secures FDA Acceptance of Teflaro
02/10 ACTAVIS : to divest US rights of Doryx to Mayne Pharma for $50m
02/10 ACTAVIS : Change in Directors or Principal Officers (form 8-K)
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF